Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
Illumina launched the BioInsight Platform, its first unified software environment combining analysis applications, genomics-focused AI, and curated biological data for genomic and multiomic research. The launch includes DRAGEN v4.6 with new deployment options across cloud and standard CPU environments, plus access to the SpliceAI2 model for rare disease research.
Key figures
- Dragen active gp2 projects
- approximately 170
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.